AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 MAY 8 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer-Scientists in Ontario, Canada have discovered that heat-directed suicide gene therapy can reduce breast cancer cell survival.
Researchers at the University of Toronto and Ontario Cancer Institute believe that treatment strategies combining gene therapy with heat could prove beneficial for overcoming the heat or radiation resistance of certain breast cancers.
"Previously, we demonstrated that infection of human breast cancer cells with a recombinant adenovirus expressing beta-galactosidase from the human heat shock protein (hsp)70b gene promoter (Ad.70b.betagal) results in 50- to 800-fold increases in reporter gene expression following heat treatment (30 minutes at 43 degrees C)," said Anthony M. Brade of the University of Toronto.
Building on that study, Brade and colleagues incorporated an Escherichia coli cytosine deaminase/herpes simplex virus thymidine kinase (CDTK) fusion gene into constructs that already contained the hsp promoter. The fusion gene causes cells to self-destruct in the presence of specific prodrugs.
Researchers infected two breast cancer cell lines (T47D and MCF-7) with the heat-directed suicide gene therapy Ad.70b.CDTK. When cells were subsequently treated with 30 minutes of mild heat and fluorocytosine and ganciclovir, clonogenic survival fell from 30- to 60-fold as compared to cells treated with either ...